
CSL Limited Announces Cessation of Securities Due to Unmet Conditions

I'm PortAI, I can summarize articles.
CSL Limited has announced the cessation of 50,194 securities due to unmet conditional rights, impacting its capital structure and stakeholders. The latest analyst rating for CSL stock (AU:CSL) is a Buy with a price target of A$225.00. CSL operates in the biotechnology sector, focusing on innovative medicines and therapies, with a current market cap of A$86.86B and an average trading volume of 1,361,230.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

